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Caveolin-1a b s t r a c t
Transforming growth factor b (TGF-b) signaling is important for many biological processes. Although
the sequential events of this cascade are known, the dynamics remain speculative. Here, live-cell
single-molecule total internal reﬂection ﬂuorescence microscopy was used to monitor the dynamics
of SMAD4, a TGF-b downstream effector, in MDA-MB-231 breast cancer cells. Contrary to previous
belief, SMAD4 was detectable at the cytoplasmic membrane, displaying two subpopulations with
different membrane docking behaviors. These subpopulations were regulated by clathrin and cave-
olin-1, and had opposing roles in the nuclear shuttling of SMAD4 and the subsequent transcriptional
regulation of genes associated with cell migration. The notion that membrane-docking behaviors of
downstream molecules could predict the cellular response to growth factors may revolutionize the
way we view cell signaling.
Structured summary of protein interactions:
SMAD4 and caveolin-1 colocalize by ﬂuorescence microscopy (View interaction)
Crown Copyright  2013 Published by Elsevier B.V. on behalf of Federation of European Biochemical
Society. All rights reserved.1. Introduction
Transforming growth factor-b (TGF-b) signaling is implicated
in the pathogenesis of many diseases, including cancer. TGF-b
can signal through SMAD transcription factors, which can inhibit
cell proliferation, while simultaneously increasing the migratory
and invasive behavior of cells [1]. TGF-b signaling is initiated by
ligand binding to the TGF-b type II receptor (TGFBRII), which trig-
gers the recruitment of TGF-b receptor type I (TGFBRI), forming a
heteromeric signaling complex at the cell membrane. Formation
of this complex leads to phosphorylation of TGFBRI and subse-
quent phosphorylation of the intracellular receptor-activated
SMAD proteins, including SMAD2 and SMAD3. Phosphorylated
R-SMAD proteins bind to SMAD4 and enter the nucleus, where
they act as transcription factors [2–6]. Although the sequentialevents of TGF-b-induced SMAD4 signaling have been relatively
well established, the transient process of SMAD4 dynamics re-
mains largely speculative, due to methodological limitations. Pre-
vious knowledge regarding cellular location and transport of
SMAD4 has mainly been obtained through in vitro biochemical
assays such as co-immunoprecipitation using cell lysates and
immunoﬂuorescence with ﬁxed or live cells [7,8]. These and other
methodologies suggest that SMAD4 shuttles between the cyto-
plasm and the nucleus. Hence, binding of SMAD4 to the recep-
tor-activated complex is generally considered as an event that
takes place in the cytoplasm.
Here, we have designed a unique approach to investigate the
dynamics of SMAD4 in live MDA-MB-231 breast cancer cells using
single-molecule total internal reﬂection ﬂuorescence microscopy
(TIRFM). TIRFM is an emerging technique that has been success-
fully applied to measure the dynamic behavior of signaling
proteins at the cell membrane, e.g. growth factor receptors, small
G proteins and ion channel receptors [9–12]. A recent study also
revealed the dynamic behavior of the GRB2 intracellular effector
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tions [13]. In the present work, we employed a live-cell single-
molecule TIRFM technique to measure the dynamics of the
intracellular SMAD4 protein in order to gain an improved
understanding of the TGF-b pathway.
2. Materials and methods
2.1. Materials
GFP-SMAD4 plasmid was generated through ampliﬁcation of
the human SMAD4 coding sequence with PCR, followed by
subcloning into the pEGFP-C1 plasmid (Clontech), as previously
described [7,8]. Clathrin heavy chain, caveolin-1 and GFP
plasmids were obtained from Axxel Biosystem LLC. TGF-b1 was
purchased from R&D, SB431542 was from Sigma and SMAD4,
clathrin heavy chain and caveolin-1 siRNA were from Thermo
Scientiﬁc. The following antibodies were acquired from cell
signaling: SMAD2, p-SMAD2, SMAD4, clathrin heavy chain, cave-
olin-1, matrix metalloproteinase-2 (MMP2), matrix metallopro-
teinase-9 (MMP9), glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), Rho GDP-dissociation inhibitor (RhoGDI) and poly
ADP ribose polymerase (PARP). Alexa 488-conjugated anti-rabbit
and IgG Alexa, 555-conjugated anti-mouse IgG were purchased
from Invitrogen. Biotin coupled GFP antibody was obtained from
Clontech.
2.2. Cell culture and transfection
Human MDA-MB-231 breast cancer cells were maintained in
DMEM containing 10% fetal bovine serum (FBS) at 37 C with 5%
CO2. The transfection of the cells was performed with lipofect-
amine 2000 (Invitrogen), according to the manufacturer’s
instructions.
2.3. Single-molecule ﬂuorescence imaging
Single-molecule ﬂuorescence imaging was performed with the
objective-type total internal reﬂection ﬂuorescence microscopy
using an inverted microscope (IX 81, Olympus), a total internal
reﬂective ﬂuorescence illuminator, a 100X/1.45NA Plan Apochro-
mat TIR objective (Olympus) and a 14-bit back-illuminated EMCCD
(Andor iXon DU-897 BV). The microscope was equipped with a CO2
incubation system (INU-ZIL-F1) and live cell imaging was per-
formed at 37 C in 5% CO2. GFP was excited at 488-nm by an argon
laser (Melles Griot) with the power of 2 mW, as measured after the
laser passed through the objective in the epi-ﬂuorescence mode.
The collected ﬂuorescent signals were passed through a HQ 525/
50 ﬁlter (Chroma Technology), before being directed to the EMCCD.
The gain of the EMCCD was set at 300. Only the central quarter of
the chip (256  256 pixels) was used for imaging analysis to en-
sure homogeneous illumination. Movies of 200 frames were ac-
quired for each sample at a frame rate of 5 Hz using MetaMorph
software (Molecular Device). The illumination time for the movies
was 40 s.
The imaging of single GFP molecules on a coverslip was per-
formed by dissolving GFP in a salt buffer (600 mM NaCl, 150 mM
PBS buffer, pH 7.4) to prevent dimer formation, followed by immo-
bilization of the protein on a coverslip by using a biotin coupled
GFP antibody, as previously reported [12]. We recognize that the
photobleaching of GFP on a glass surface may differ slightly from
the photobleaching of GFP on a biological membrane. However,
this technique for determining bleaching parameters is generally
accepted in the literature.2.4. Analysis of single-molecule ﬂuorescence intensity
Analysis of single-molecule ﬂuorescence intensity in movies
acquired from living cells was achieved by subtracting the back-
ground ﬂuorescence from the ﬁrst two frames following the
appearance of a ﬂuorescent spot, using the rolling ball method
in the Image J software (NIH). In the experiments two forms of
SMAD4 molecules could be detected. One was temporarily docked
to the surface, while the other was continuously diffusing. Since
the continuously moving molecules could only be observed for
less than three frames, these were excluded from analysis. An
intensity of four times that of an area lacking ﬂuorescent spots
was used as a threshold to identify spots, which were then
ﬁltered with Matlab. For the analysis of ﬂuorescence intensity,
regions of interest were selected according to a previously
described procedure [12].
2.5. Analysis of single-molecule on-time
Single-molecule GFP-SMAD4 trajectories were extracted with
MetaMorph tracking software (Molecular Device). Two types of
trajectories were observed, those that appear and disappear during
a movie and those that are cut off due to the beginning or ending of
a movie, i.e. objects that are present in the ﬁrst or last frame of the
movie. For the former, the on-time is equal to the length of time
between the appearance and disappearance of the ﬂuorescent spot.
For the latter, the precise on-time is unknown and these spots were
excluded from analysis. The on-times were ﬁtted to a series of
models that differed in the number and types of sub-distributions.
The goal was to identify the minimal number of kinetically distinct
subpopulations that could account for the overall on-time distribu-
tion. Model selection was achieved using two strategies, as previ-
ously described [14]. The ﬁrst strategy involved the minimization
of the Bayesian Information Criterion (BIC), were the ﬁtting error
was approximated to follow a normal distribution. The application
of the BIC requires a priori knowledge of the distribution of exper-
imental errors, which is unknown for on-time data. Hence, the
nonparametric test of the distribution of exponential decay was
also used.
2.6. TIRFM imaging for protein co-localization
For the cell membrane protein co-localization study, TGF-b1
stimulated cells were ﬁxed with 4% paraformaldehyde and per-
meabilized with 0.1% Triton X-100. Nonspeciﬁc sites were
blocked with 1% BSA in PBS containing 0.1% Tween-20 (PBST). Pri-
mary and secondary antibodies were diluted in 1% BSA in PBST.
Fluorescence imaging of the cell membrane was performed with
the objective-type TIRFM as mentioned above. A 488 nm laser
and 561 nm argon ion laser were used to excite Dylight 488
and Alexa 555, respectively. The signals were detected with a
dual-view optics Dual-View™ (Optical Insight) mounted in front
of the EMCCD. The Dual-View™ ﬁlter cube consisted of a ﬁxed di-
chroic ﬁlter (565dcxr, Chroma technology) and two emission
ﬁlters (D525/50 and D605/50, Chroma Technology). The
ﬂuorescence from the individual molecules was passed through
the Dual-View™ ﬁlter box. The images with different colors were
obtained from two parts of the EMCCD. Namely, two different
pictures were captured and later merged together. The position
of the spots did not change, since the cells were ﬁxed. 6–8 cells
were used for the SMAD4 and clathrin/caveolin-1 co-localization
studies. The co-localization coefﬁcient was calculated by dividing
the number of co-localized SMAD4 spots with the total number of
SMAD4 spots in a cell.
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MDA-MB-231 cells were grown in 35 mm dishes for 24 h, and
transfected with control siRNA (siControl), clathrin heavy chain
siRNA (siCLTC), caveolin-1 siRNA (siCav-1), SMAD4 siRNA, control
plasmid (plControl), clathrin heavy chain plasmid (plCLTC) or cave-
olin-1 plasmid (plCav-1). The transfected cells were starved for 4 h
and then treated with TGF-b1 for 1 h. Potassium depletion was per-
formed as previously described. The treated cells were ﬁxed with
4% paraformaldehyde and permeabilized with 0.1% Triton X-100.
Nonspeciﬁc sites were blocked with 1% BSA in PBST. The ﬁxed cells
were incubated with Smad2 and SMAD4 monoclonal rabbitFig. 1. Single-molecule imaging of GFP-SMAD4 docking to the cell membrane. (A and B)
with (B) TGF-b1 stimulation in living MDA-MB-231 cells. (Scale bar: 4 lm). (C) Distr
stimulated cells. The solid curve shows the ﬁtting of the Gaussian function and the arro
intensity at a single binding site plotted against time. (E) Identiﬁcation of two subpopul
on-times detected by TIRFM. The on-times for each event were determined from the
subpopulations with shorter-on-time (red line) and longer-on-time (green line).primary antibodies overnight (1:200 dilution), followed by wash-
ing and incubation with Alexa 488-conjugated anti-mouse IgG sec-
ondary antibody for 1 h at room temperature (1:500 dilution). All
the antibodies were diluted in PBST solution containing 1% BSA.
Fluorescence imaging was performed by confocal microscopy
(Olympus IX81).
2.8. Western blot assay
MDA-MB-231 cells were grown in 6-well plates for 24 h, fol-
lowed by transfection with control siRNA (siControl), clathrin hea-
vy chain siRNA (siCLTC), caveolin-1 siRNA (siCav-1), SMAD4 siRNA,TIRFM visualization of GFP-SMAD4 bound to the plasma membrane without (A) and
ibution of the ﬂuorescence intensities of diffraction-limited GFP-SMAD4 spots in
whead indicates the peak positions of the ﬁtting curve. (D) Changes in ﬂuorescence
ations of GFP-SMAD4. The grey histogram shows the distribution of all GFP-SMAD4
ﬂuorescence intensity. The data was best-ﬁt to represent two kinetically distinct
Fig. 2. Distinct dynamic patterns of SMAD4membrane docking mediated by clathrin and caveolin-1. (A) Dual-view TIRFM imaging of SMAD4 and clathrin or caveolin-1 in the
presence of TGF-b1. (B–E) Identiﬁcation of two dynamic SMAD4 membrane docking patterns regulated by expression of clathrin heavy chain (CLTC) or caveolin-1 (Cav-1). (B),
CLTC knock-down, (C), CLTC overexpression, (D), Cav-1 knock-down, (E), Cav-1 overexpression. Grey histograms show the distribution of all GFP-SMAD4 on-times detected
by TIRFM. These data were best ﬁt to form two kinetically distinct subpopulations with shorter on-time (red line) and longer on-time (green line).
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or caveolin-1 plasmid (plCav-1). The transfected cells were starved
for 4 h and then treated with TGF-b1 for 1 h. The treated cells were
washed and incubated with lysis buffer containing protease and
phosphatase inhibitors. Protein lysates were mixed with SDS load-
ing buffer and heated at 95 C for 5 min. Samples were ran in Any
KD gels (Bio-Rad) and transferred to PVDF membranes. Mem-
branes were blocked for 1 h in 5% nonfat milk in TBST (Tris Buf-
fered Saline with 0.1% Tween-20), incubated with desired
primary antibody overnight, washed and incubated with HRP-con-
jugated secondary antibody for 1 h. Membranes were washed and
bands were detected by enhanced chemiluminescence (Amersham
Life Sciences).
2.9. Real-time RT-PCR
RNA extraction was performed using the ALLPrep RNA Kit (QIA-
GEN), according to the manufacturer’s instructions, and samples
were quantiﬁed by absorption spectroscopy. Real-time RT-PCR
was conducted as previously described [15].
2.10. Migration and invasion assay
Migration and invasion assays were performed to investigate
TGF-b1-induced cell migration. MDA-MB-231 cells were grown in
6-well plates for 24 h, and transfected with control siRNA (siCon-
trol), clathrin heavy chain siRNA (siCLTC), caveolin-1 siRNA (si-
Cav-1), SMAD4 siRNA, control plasmid (plControl), clathrin heavy
chain plasmid (plCLTC) or caveolin-1 plasmid (plCav-1). TheFig. 3. Nuclear translocation of SMAD2 and SMAD4 in the presence of SB431542 (SB)
caveolin-1 (Cav-1). (A) Immunoﬂuorescence imaging of TGF-b1 induced nuclear impo
cytoplasmic (C) and nuclear (N) fractions, veriﬁed with antibodies against RhoGDI andtransfected cells were starved for 4 h. For the migration assay the
transfected cells were incubated with 10 ng/ml TGF-b1 in the pres-
ence of in 1% FBS media for 8 h. Cells that migrated through the
pores of the ﬁlter were stained and counted in triplicates using
QCMTM 24-Well Cell Migration Assay (Millipore), according to the
manufacturer’s instructions. For the invasion assay the transfected
cells were incubated with 10 ng/ml TGF-b1 in the presence of in 3%
FBS media for 24 h. The assay was performed in triplicates using
QCMTM 24-Well Cell Invasion Assay (Millipore) according to the
manufacturer’s instructions.
2.11. Statistical analysis
Data is presented as the mean ± S.E.M. The statistical signiﬁ-
cance between two samples was assessed by the paired Student’s
t-test.
3. Results
3.1. TGF-b1 induced membrane docking of SMAD4
Contrary to previous belief, we found that SMAD4 was detect-
able at the cytoplasmic membrane in the presence of TGF-b1.
Transfecting cells with GFP-SMAD4 plasmid enabled visualization
of SMAD4 (Fig. 1A and B, Supplementary Video 1). Conversely, cells
transfected with a control GFP plasmid did not exhibit any ﬂuores-
cent spots (Fig. S1C), suggesting that SMAD4 is responsible for the
presence of the recombinant protein at the membrane. The ﬂuores-
cence intensity distribution of the spots (Fig. 1C) was similar to, plasmids (pl) and small interfering RNA (si) for clathrin heavy chain (CLTC) and
rt of SMAD2 and SMAD4 (B) Nuclear translocation of SMAD2 and SMAD4 using
PARP.
Fig. 4. The effect of clathrin heavy chain (CLTC) and caveolin-1 (Cav-1) on TGF-b1 induced MMP2 and MMP9 mRNA and protein expression. (A) The mRNA expressions of
MMP2 and MMP9 were measured by RT-PCR. (B) The protein expressions of MMP2 and MMP9 were measured by Western blot. Cell migration (C) and invasion (D) were
measured using colorimetric assays. Results are expressed as the mean fold change (±S.E.M.) compared with the control siRNA (siControl) or control plasmid (plControl) and
normalized to GAPDH. ⁄P < 0.05, ⁄⁄P < 0.01.
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that each spot represents a single recombinant protein. To ensure
that the membrane translocation of SMAD4 was dependent on
activation of the TGF-b pathway, cells were imaged after treatment
with SB431542, an inhibitor of TGFBRI phosphorylation (Fig. S1A
and B). In the presence of the inhibitor, SMAD4 could not be de-
tected at the cell membrane.
The discovery that SMAD4 associates with the plasma mem-
brane led us to explore the dynamic behavior of this protein at
the cell surface. In order to establish an unbiased and completeinventory of all visible GFP-SMAD4 trajectories, previously re-
ported particle tracking software and statistical methods were em-
ployed [14] (see Methods). The membrane docking time and
intensity trace of each GFP-SMAD4 molecule was determined by
measuring the ﬂuorescence on-time, which refers to the time when
the ﬂuorescent signal ﬁrst appears at the membrane to the time
when it disappears (Fig. 1D, Fig. S3). By analyzing the on-time
behaviors we identiﬁed two dynamically distinct SMAD4 subpop-
ulations. The short-lived subpopulation had an on-time of 1.8 s,
while the long-lived one had an on-time of 5.4 s (Fig. 1E).
Fig. 4 (continued)
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aching time for a single GFP molecule under identical excitation
conditions (12.0 s) (Fig. S2B), suggesting that the association and
dissociation of SMAD4 caused the transient appearance of a ﬂuo-
rescent signal at the cell membrane, rather than the photobleach-
ing of GFP. It is possible that on-times longer than 3.5 s (Fig. S2B)
could be slightly affected by GFP photobleaching, however this
contribution is minimal.
3.2. Clathrin and caveolin-1 regulate SMAD4 membrane docking
Next, we investigated the underlying mechanism for the pres-
ence of two distinct sub-populations of this protein at the mem-
brane. We speculated that the on-time patterns stemmed from
the association of SMAD4 with two different membrane domains.
As clathrin and caveolin-1 membrane pits have been implicated
in TGF-b signaling [16–18], we hypothesized that they may be
responsible for mediating SMAD4 dynamics. Using immunoﬂuo-
rescence imaging of ﬁxed cells, we studied the potential colocaliza-
tion between SMAD4 and clathrin or caveolin-1. Indeed, there were
regions on the cell membrane were the proteins co-localized
(Fig. 2A). The partition coefﬁcient for co-localization of SMAD4
with clathrin or caveolin-1 was approximately 29% and 44%,
respectively. Next, we used siRNA and plasmid vectors to down-
regulate and overexpress clathrin or caveolin-1. The results indi-
cate that caveolin-1 and clathrin induce shorter and longer
SMAD4 docking times, respectively (Fig. 2B and E).3.3. Clathrin and caveolin-1 regulate nuclear translocation of SMAD4
It has previously been shown that clathrin promotes TGF-b sig-
naling transduction, while caveolin-1 mediates degradation of the
receptor complex [19]. However, the speciﬁc intracellular trans-
port of SMAD4 in response to clathrin or caveolin-1 expression
has not been determined. Confocal microscopy and western blot
results revealed that clathrin overexpression increased SMAD4
translocation to the nucleus, while caveolin-1 overexpression did
the opposite (Fig. 3A). These observations demonstrate the oppos-
ing roles of the membrane domains in TGF-b signaling. Interest-
ingly, while SMAD4 shuttling was affected by the expression of
clathrin and caveolin-1, it was independent of endocytosis. Inhibi-
tion of endocytosis by incubating cells with potassium-free media
did not affect the dynamics of SMAD4 membrane docking or hin-
der the translocation of SMAD4 to the nucleus (Fig. S4A–D). These
results suggest that clathrin and caveolin-1 mediate SMAD4 intra-
cellular transport by an endocytosis-independent mechanism.
Since phosphorylated SMAD2 is able to bind to SMAD4, we also
investigated the intracellular trafﬁcking of SMAD2 in response to
varying levels of clathrin or caveolin-1. There also exists contro-
versy regarding whether the phosphorylation and nuclear translo-
cation of SMAD2 is dependent on endocytic pathways [18,20].
Here, we demonstrate that the phosphorylation and translocation
of SMAD2 are independent of clathrin/caveolin-1 expression as
well as endocytosis (Fig. 3B, Figs. S4B and C and S5). Moreover,
the suppression of SMAD4 using siRNA did not affect the shuttling
Y. Yang et al. / FEBS Letters 587 (2013) 3912–3920 3919of SMAD2 (Fig. S6), indicating that the intracellular dynamics of
SMAD2 were independent of SMAD4.
3.4. SMAD4 dynamics determine transcriptional regulation
As can be expected from the nuclear translocation studies, we
demonstrate that clathrin expression increases SMAD4 induced
gene transcription. Western blot and PCR experiments indicate
that clathrin overexpression and caveolin-1 downregulation stim-
ulate increased mRNA and protein levels of a variety of genes that
have been shown to be transcriptionally regulated by SMAD4,
including plasminogen activator inhibitor-1 (PAI-1), laminin gam-
ma 2 (LAMC2), matrix metalloproteinase-2 (MMP2) and matrix
metalloproteinase-9 (MMP9) [21–23] (Fig. S7, Fig. 4A and B). These
observations suggest that longer SMAD4 on-times correlate with
nuclear translocation and gene activation, while shorter on-times
are associated with the interruption of signal transduction. To fur-
ther insure that the above-mentioned transcriptional response was
mediated by SMAD4, anti-SMAD4 siRNA was employed, resulting
in the suppression of transcription, despite the overexpression of
clathrin (Fig. S8A–C).
3.5. SMAD4 dynamics regulate cell migration in vitro
As indicated by the results above, SMAD4 dynamics regulate the
production of various mRNAs and proteins. Hence, we asked
whether the expression of SMAD4 and clathrin and caveolin-1 re-
sult in phenotypical changes in cell behavior that have been asso-
ciated with TGF-b signaling. By using cell migration and invasion
assays we illustrate that the expression of clathrin increases migra-
tory behavior in vitro, while caveolin-1 has the opposing effect
(Fig. 4C and D). Anti-SMAD4 siRNA was employed to verify that
SMAD4 was responsible for inducing this response (Fig. S8D and
E). Hence, longer SMAD4 on-times induced by clathrin causes the
cells to display a migratory phenotype.4. Discussion
In this study we performed live-cell single-molecule imaging
using TIRFM to investigate the dynamics of SMAD4, a downstream
effector of the TGF-b pathway. To the best of our knowledge, this is
the ﬁrst report showing that the dynamics of an intracellular pro-
tein can be monitored on the single-molecule level in living cells.
By employing this novel technique we were able to gain new in-
sight into the TGF-b pathway, which would not have been possible
with traditional imaging modalities.
In conclusion, we found that SMAD4 can dock to the cytoplas-
mic membrane in the presence of TGF-b, contrary to previous be-
lief that SMAD4 only shuttles between the cytoplasm and the
nucleus. In addition, we demonstrate that clathrin and caveolin-1
are responsible for the enrichment and suppression of subpopula-
tions of SMAD4 with distinct dynamic behavior at the cell mem-
brane. The expression of clathrin resulted in longer SMAD4 on-
times, while caveolin-1 enhanced the SMAD4 subpopulation with
shorter membrane docking times. The results also indicate that
clathrin and caveolin-1 have opposing roles in the nuclear translo-
cation of SMAD4, and the subsequent transcriptional gene activa-
tion and induction of migratory cell behavior. Furthermore, we
show that the shuttling of SMAD4 may in certain circumstances
be independent of SMAD2, suggesting that other proteins could
be involved in the nuclear translocation and/or membrane docking
of SMAD4.
The presence of SMAD4 at the membrane may not be an iso-
lated event. The observation that a downstream effector, thought
to solely exist in the cytoplasm and nucleus, associates with themembrane with distinct dynamic patterns may pertain to several
signaling pathways. The results warrant further investigation into
the dynamic behavior and cellular location of downstream effector
proteins in various signaling pathways. The notion that the mem-
brane docking behaviors of downstream molecules could predict
the cellular response to growth factors could revolutionize the
way we view and study cell signaling.
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